|
|
 |
|
Viewing report
|
|
|
Sepracor Inc.: PharmaVitae Profile
Datamonitor, March 2009, Pages: 105
This analysis examines the historical and forecast performance for Sepracor in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to purchase this title
- Benchmark Sepracors performance against key rivals in the prescription pharmaceutical sector
- Assess the challenges facing the companys enantiomer-driven portfolio
- See how externalization strategies will help Sepracor to secure its long-term profitability
|
|
|
|
